Annual bicycle ride aims to save lives Beloit Daily News Wed, 30 Jun 2010 14:14 PM PDT âWhere is the Sleeping Bear?...â A group of area bicyclists will find out when they depart Monday for the 2010 David Browne Ride. Now in its eighth year, this annual bicycle ride is a fundraiser for the American Heart Association in the name of a Beloit College alumnus who died of heart disease at the age of 24. | Testosterone gel linked to heart problems Reuters via Yahoo! News Wed, 30 Jun 2010 14:14 PM PDT Testosterone treatments may build muscle mass in older men, but they may carry a risk of heart problems in people with poor mobility, U.S. researchers said on Wednesday. | Adverse Cardiovascular Events Reported in Testosterone Trial in Older Men National Institutes of Health Wed, 30 Jun 2010 14:06 PM PDT A clinical trial of testosterone treatment in older men, reported June 30 online in the New England Journal of Medicine, has found a higher rate of adverse cardiovascular events, such as heart attacks and elevated blood pressure, in a group of older men receiving testosterone gel compared to those receiving placebo. | Testosterone Gel Could Raise Heart Risks in Frail, Older Men HealthDay via Yahoo! News Wed, 30 Jun 2010 14:02 PM PDT WEDNESDAY, June 30 (HealthDay News) -- Older men in poor health who use testosterone gel to boost their mobility may raise their odds of high blood pressure or heart attack, new research suggests. | (AFX UK Focus) 2010-06-30 21:07 UPDATE 1-US FDA probes possible risks of Lilly drug, others Interactive Investor Wed, 30 Jun 2010 13:33 PM PDT WASHINGTON, June 30 (Reuters) - U.S. regulators have launched probes into possible risks of an Eli Lilly and Co bloodthinner, a Sanofi-Aventis heart drug and other medicines. The Food and Drug Administration released its quarterly list of early investigations into health problems reported with various drugs on Wednesday. On the list, the agency said it was probing cases of thrombotic ... | Heart attack risk target of pill trial NZCity Wed, 30 Jun 2010 13:32 PM PDT 1 July 2010 New Zealanders at high risk of heart attack or stroke may soon have one pill to replace their multiple medications. | When is a drug too risky to stay on the market? MSNBC Wed, 30 Jun 2010 13:26 PM PDT The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. Rofecoxib - Multiple sclerosis - Health - Conditions and Diseases - Arthritis | | |
|
No comments:
Post a Comment